The compensation of Hanmi over violating the patent is judged to be KRW 10 million… “Got a minute to breath”

The court ruled Hanmi Pharm, which violated the patent related to the schizophrenia treatment, Zyprexa, to compensate KRW 10 million.

Since it was a judgment which did not accept the damage caused by the price reduction of the original product, it is analyzed that Hanmi Pharm has practically won the suit.

On the 19^th, the 12^th Civil Affair Department of the Seoul Central District Court declar...